Cargando…

The value and limitations of new oral anticoagulant plasma level assessments

The class of new oral anticoagulants (NOACs) has been developed to provide reliable oral anticoagulation without the need for therapeutic drug monitoring. Based on phase I and II trials and pharmacokinetic and pharmacodynamic modeling, fixed drug doses have been selected for large phase III clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van der Linden, Lorenz, Hias, Julie, Vanassche, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Supplement Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850711/ https://www.ncbi.nlm.nih.gov/pubmed/35185407 http://dx.doi.org/10.1093/eurheartj/suab153

Ejemplares similares

Venous thromboembolism in the elderly: efficacy and safety of non-VKA oral anticoagulants
por: Geldhof, Vincent, et al.
Publicado: (2014)

Medication review versus usual care to improve drug therapies in older inpatients not admitted to geriatric wards: a quasi-experimental study (RASP-IGCT)
por: Van der Linden, Lorenz, et al.
Publicado: (2018)

Non-vitamin K antagonist oral anticoagulants in patients with valvular heart disease
por: Fanaroff, Alexander C, et al.
Publicado: (2022)

Non-vitamin K antagonist oral anticoagulants in older and frail patients with atrial fibrillation
por: Giugliano, Robert P
Publicado: (2022)

Valuing diversity in value assessment: introducing the PhRMA Foundation Health Disparities Challenge Award
por: Onukwugha, Eberechukwu
Publicado: (2021)

Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation
por: Farinha, José Maria, et al.
Publicado: (2022)

The impact of a pharmacist intervention on post-discharge hypnotic drug discontinuation in geriatric inpatients: a before-after study
por: Van der Linden, Lorenz, et al.
Publicado: (2023)

Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with advanced chronic kidney and liver diseases
por: Liao, Jo-Nan, et al.
Publicado: (2022)

Incorporating health equity into value assessment: frameworks, promising alternatives, and future directions
por: Diaby, Vakaramoko, et al.
Publicado: (2021)

Nutrient reference values for bioactives: new approaches needed? A conference report
por: Biesalski, Hans Konrad, et al.
Publicado: (2013)

“It’s Time to Represent”: shifting the paradigm to improve the quality of inputs into value assessment frameworks
por: Moczygemba, Leticia R, et al.
Publicado: (2021)

Abstract 28. Novel Oral Anticoagulants (NOACs) in Microsurgery: A Review
por: Yao, Amy, et al.
Publicado: (2017)

Direct oral anticoagulant plasma levels and thrombin generation on ST Genesia system
por: Pfrepper, Christian, et al.
Publicado: (2020)

Coagulation assessment with the new generation of oral anticoagulants
por: Pollack, Charles V
Publicado: (2016)

Fidaxomicin Attains High Fecal Concentrations With Minimal Plasma Concentrations Following Oral Administration in Patients With Clostridium difficile Infection
por: Sears, Pamela, et al.
Publicado: (2012)

The Value of Preventive Medicine: A Look at Vaccine Management
por: Armstrong, Edward P., et al.
Publicado: (2007)

Shifting the Focus From Cost to Value: Key Stakeholder Perspectives
por: Chao, Schumarry H., et al.
Publicado: (2006)

Modernization Versus Limitation: Cross-Firing the Impact of the AHRQ Effective Health Care Program on Access to Biologic Therapies
por: Chao, Schumarry H., et al.
Publicado: (2007)

Direct Oral Anticoagulants for Pulmonary Embolism: Importance of Anatomical Extent
por: Brekelmans, Marjolein P. A., et al.
Publicado: (2018)

Serum or Plasma for Quantification of Direct Oral Anticoagulants?
por: Aakerøy, Rachel, et al.
Publicado: (2022)

Target-Specific Oral Anticoagulants—New Approaches in the Field of Oral Anticoagulation
por: Mani, Helen, et al.
Publicado: (2015)

New horizons in anticoagulation: Direct oral anticoagulants and their implications in oral surgery
por: Serrano-Sánchez, Víctor, et al.
Publicado: (2017)

Use of New Oral Anticoagulants / Direct Oral Anticoagulants in Malignant Patients
por: Khan, Yusra, et al.
Publicado: (2020)

Nutrient reference value: non-communicable disease endpoints—a conference report
por: Lupton, J. R., et al.
Publicado: (2016)

The Role of Anticoagulation Clinics in the Era of New Oral Anticoagulants
por: Testa, Sophie, et al.
Publicado: (2012)

Management of bleeding in patients on direct oral anticoagulants in emergency department: where we are and where we are going
por: De Marco, Francesca, et al.
Publicado: (2023)

Direct oral anticoagulant plasma levels in hospitalized COVID-19 patients treated with dexamethasone
por: Potere, Nicola, et al.
Publicado: (2021)

A Cluster-based, Spatial-sampling Method for Assessing Household Healthcare Utilization Patterns in Resource-limited Settings
por: Yu, Alexander T, et al.
Publicado: (2020)

Nutrition issues in Codex: health claims, nutrient reference values and WTO agreements: a conference report
por: Aggett, Peter J., et al.
Publicado: (2012)

Using latent class and quantum models to value equity in health care: a tale of 2 stories
por: Ngorsuraches, Surachat
Publicado: (2021)

Structural damage in rheumatoid arthritis as visualized through radiographs
por: van der Heijde, Désirée
Publicado: (2002)

The new in anticoagulation: factor XI inhibitors
por: Muscente, Francesca, et al.
Publicado: (2023)

Assessing the knowledge of medical undergraduates on oral anticoagulation therapy
por: Sarkar, Chayna, et al.
Publicado: (2023)

AHRQ’s Comparative Effectiveness Research on Oral Medications for Type 2 Diabetes: A Summary of the Key Findings
por: Bennett, Wendy L., et al.
Publicado: (2012)

Plasma levels of alpha-1-antichymotrypsin are elevated in patients with chronic heart failure, but are of limited prognostic value
por: Lok, S. I., et al.
Publicado: (2014)

Levels of Physical Activity among Participants in the JACC Study
por: Kurozawa, Youichi, et al.
Publicado: (2005)

Assessing the Risk of Vaccine-derived Outbreaks After Reintroduction of Oral Poliovirus Vaccine in Postcessation Settings
por: Fu, Rui, et al.
Publicado: (2018)

Effect of dexamethasone on direct Xa-inhibitor oral anticoagulant plasma levels in patients with COVID-19
por: Bosch, Floris T.M., et al.
Publicado: (2021)

Under-5 mortality due to HIV: regional levels and 1990–2009 trends
por: Stanecki, Karen, et al.
Publicado: (2010)

Expanding use of new oral anticoagulants
por: Weitz, Jeffrey I.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gpqkmpbk9u9q2991pib9k7ri9u